Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Theres also some data on it for helping women with endometriosis and uterine fibroids as well
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Discontinuation rates under 6% even at the highest dose indicate that the gastrointestinal burden, while present, is not prohibitive
Laboratory research record on GLP-1S [PMID: 39093590] PubMed laboratory record discussing GLP-1S in a research context
MTHFR, methylene tetrahydrofolate reductase
US$ 21.66
US$ 24.60
US$ 23.78
US$ 27.64
US$ 22.23
US$ 29.69
US$ 22.31
US$ 27.89
US$ 24.91
